NASDAQ: AEGR
Price:
22.81
Change:
- 0.14
Day High:
23.57
Day Low:
22.48
Volume:
1,058,400
4:00 PM ET on Dec 19, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Press Releases


All 2014 Releases
View Summary Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Dec 8, 2014
PDF 10.1 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals to Present at the Deutsche Bank BioFEST Conference
Nov 21, 2014
PDF 10.2 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Nov 12, 2014
PDF 10.1 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Acquires Myalept(TM) From AstraZeneca
Nov 6, 2014
PDF 21.0 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Announces Third-Quarter 2014 Financial Results
Oct 30, 2014
PDF 29.5 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals to Announce Third-Quarter 2014 Financial Results on Thursday, October 30
Oct 27, 2014
PDF 10.1 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Oct 8, 2014
PDF 10.1 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Announces Presentation at the Leerink Rare Disease Roundtable
Sep 24, 2014
PDF 10.1 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Observes Familial Hypercholesterolemia Awareness Day
Sep 24, 2014
PDF 9.6 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Sep 9, 2014
PDF 10.0 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference
Sep 3, 2014
PDF 10.1 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Announces Resolution of Warning Letter for JUXTAPID(R) (lomitapide) Capsules
Aug 27, 2014
PDF 8.8 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals, Inc. Prices $300 Million Convertible Senior Notes Offering
Aug 12, 2014
PDF 11.8 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals, Inc. Announces Intention to Offer $250 Million of Convertible Notes
Aug 11, 2014
PDF 11.2 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Aug 8, 2014
PDF 10.0 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Appoints Craig Fraser as Chief Operating Officer
Jul 30, 2014
PDF 10.4 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Announces Second-Quarter 2014 Financial Results
Jul 29, 2014
PDF 27.6 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals to Announce Second Quarter 2014 Financial Results on Tuesday, July 29
Jul 22, 2014
PDF 9.9 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Jul 9, 2014
PDF 10.0 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Jun 6, 2014
PDF 10.0 KB Add to Briefcase
Showing 1-20 of 39 Page: 1 2  Next 20
Add to Briefcase = add release to Briefcase